Select Page
nonconforming materials report

FDA 2024 Annual Report on the State of Pharmaceutical Quality 

The Office of Pharmaceutical Quality, U.S. Food and Drug Administration, and Center for Drug Evaluation and Research provides valuable insight into trends with drug manufacturers, the drug supply, and biological products in this report. 

To learn more about  the 2024 State of Pharmaceutical Quality, fill out the form to read our white paper!

Get your FREE White Paper here!


* These fields are required.